Vietnam meluluskan vaksin HFMD pertamanya, ENVACGEN®, dalam langkah penting menangani penyakit tangan, kaki dan mulut, sambil Medigen dan Substipharm memperluas akses vaksin di Asia Tenggara.
Vietnam has approved its first HFMD vaccine, ENVACGEN®, marking a major step in tackling hand, foot and mouth disease as Medigen and Substipharm expand across Southeast Asia. Rollout in Vietnam signals shift towards prevention-led child healthcare in ASEAN
Malaysia is emerging as a leader in innovation, earning recognition from international organizations and countries around the world. The Malaysian Innovation Foundation, or Yayasan Inovasi Malaysia is a key player in this success, fostering innovation and addressing social challenges through local technology and innovative solutions. In an interview during a media get-together recently, the CEO of YIM, Dr Sharmila Mohamed Salleh, shares insights into the foundation's role, achievements, future plans and its functions in the innovation ecosystem.